Literature DB >> 12579289

Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression.

Hitoshi Miyashita1, Shiro Mori, Katutoshi Motegi, Manabu Fukumoto, Takafumi Uchida.   

Abstract

Phosphorylation of serine or threonine residue preceding proline (Ser/Thr-Pro) is a key regulatory mechanism. The conformation of certain phosphorylated Ser/Thr-Pro bonds is regulated specifically by the prolyl isomerase Pin1. Inhibition of Pin1 induces apoptosis and may contribute to neuronal death in Alzheimer's disease. It has been reported that Pin1 is strikingly overexpressed in a subset of human tumors. The differential display screen revealed that Pin1 increases the transcription of several target genes, including cyclin D1 and c-myc genes. Pin1 cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. Pin1 also regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with adenomatous polyposis coli protein (APC). However, the analysis of Pin1 expression has not been demonstrated in human oral squamous cell carcinoma (OSCC). We examined the expression of Pin1 mRNA and protein in OSCC cell lines, and analyzed Pin1/cyclin D1/beta-catenin expression in OSCC clinical samples by immunohistochemical staining. We report that Pin1 is overexpressed in OSCC and its level correlates with cyclin D1 level. These results indicate that Pin1 is related to oncogenesis of OSCC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579289

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

1.  Expression of Pin1 and Ki67 in cervical cancer and their significance.

Authors:  Hongyu Li; Hongling Shen; Qian Xu; Dongrui Deng; Shixuan Wang; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 2.  Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?

Authors:  Peter E Shaw
Journal:  EMBO Rep       Date:  2007-01       Impact factor: 8.807

Review 3.  Prolyl isomerase Pin1 in cancer.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Res       Date:  2014-08-15       Impact factor: 25.617

4.  Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population.

Authors:  Yonghe You; Jieqiong Deng; Jian Zheng; Lan Jiang; Na Li; Hongchun Wu; Wei Li; Jiachun Lu; Yifeng Zhou; Bin Ni
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

5.  A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity.

Authors:  Jiachun Lu; Zhibin Hu; Sheng Wei; Li-E Wang; Zhensheng Liu; Adel K El-Naggar; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

Review 6.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

7.  Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma.

Authors:  Yan Lu; Guo-Liang Huang; Xing-Xiang Pu; Yu-Xiang He; Bin-Bin Li; Xing-Yan Liu; Zigang Dong; Zhiwei He
Journal:  Mol Biol Rep       Date:  2012-12-27       Impact factor: 2.316

8.  The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.

Authors:  Anamitra Ghosh; Hariharan Saminathan; Arthi Kanthasamy; Vellareddy Anantharam; Huajun Jin; Gautam Sondarva; Dilshan S Harischandra; Ziqing Qian; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

9.  Lack of association between the PIN1 promoter -667T>C (rs2233679) polymorphism and cancer risk: Evidence from meta-analysis.

Authors:  Liangjun Tao; Yisheng Chen; Lingsong Tao; Jian Kong; Haibo Qin; Jie Zheng; Bin Zou; Sizhong He
Journal:  Biomed Rep       Date:  2014-01-22

10.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.

Authors:  Prudence B Lam; Laura N Burga; Bryan P Wu; Erin W Hofstatter; Kun Ping Lu; Gerburg M Wulf
Journal:  Mol Cancer       Date:  2008-12-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.